SEC Form 4/A · accession 0001209191-15-055645
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Joseph L Turner
Director
Period of report
Jun 18, 2015
Accepted (ET)
Jun 23, 2015 · 3:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common stock (Right to purchase)F2,F1 | $6.55 | Jun 18, 2015 | A | 50,000 | A | — | Jun 18, 2025 | Common stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 18, 2015 so that the entirety of the option grant will vest on or before the date of Corcept's next Annual Meeting of Stockholders.
- F2The Form 4, as originally filed, incorrectly reported the number of shares in section 7 and 9 under Table II. The Form 4, as amended by this Form 4/A, correctly reports such information.